Treatment of COVID-19 late consequences

Programme 2014 - 2020 INTERREG V-A Sweden - Denmark - Norway (Öresund - Kattegat - Skagerrak)

Date of latest update: 2022-11-04

Description

Description (EN):

Treatment of COVID-19 late followers works to better understand the late effects of the corona and find better ways to mitigate them. The Corona pandemic has made clear signs on our societies from the economic, social and health point of view. The pandemic seems to be following us for many years yet, with severe late consequences not previously experienced from influenza and other viral epidemics. COVID-19 is a new disease. We know very little about late sequences, who is affected and for how long. In the aftermath of the widespread infection, a large dark number is assumed, some of which live with severe late effects of COVID-19. The project partners want to understand the emergence of late consequences and to be able to mitigate them. The project will create an overview of late sequences and improve treatment with a Danish-Swedish biobank to identify biomarkers for late sequences, late sequence clinics for the treatment of clear late sequences and mapping non-specific late sequences. It creates knowledge of how the rehabilitation of late sequences is most optimally arranged. The collaboration will lead to joint solutions by combining expertise from both Denmark and Sweden with competencies within a number of specialties supported by publications on the scientific cooperation.

Description (DA):

Behandling af COVID-19 senfølger arbejder for bedre at forstå senfølgerne fra corona og finde bedre måder at kunne afbøde dem. Corona-pandemien har sat tydelige spor på vores samfund økonomisk, socialt og sundhedsmæssigt. Pandemien ser ud til at følge os mange år endnu med alvorlige senfølger ikke tidligere oplevet fra influenza- og andre virusepidemier. COVID-19 er en ny sygdom. Vi ved meget lidt om senfølger, hvem der er rammes og i hvor lang tid. I kølvandet på den udbredte smitte formodes et stort mørketal, hvoraf nogle lever med alvorlige senfølger af COVID-19. Projektets partnere ønsker at forstå opståen af senfølger og at kunne afbøde dem. Projektet vil skabe overblik over senfølger og forbedre behandlingen med en dansk-svensk biobank til at identificere biomarkører for senfølger, senfølgerklinikker til behandling af tydelige senfølger og kortlægge uspecifikke senfølger. Det skaber viden om, hvordan rehabiliteringen af senfølger indrettes mest optimalt. Samarbejdet vil føre til fælles løsninger ved at forene ekspertise fra både Danmark og Sverige med kompetencer inden for en række specialer, som understøttes af udgivelser omkring det videnskabelige samarbejde.

Website: http://www.interreg-oks.eu/

Thematic information

Health and social services

Specific Objective: Increase the applied research and innovation oriented activity in the ÖKS (Öresund-Kattegat-Skagerrak) area

Thematic Objective: (01) strengthening research, technological development and innovation by:

Investment Priority:

(01b) promoting business investment in R&I, developing links and synergies between enterprises, research and development centres and the higher education sector, in particular promoting investment in product and service development, technology transfer, social innovation, eco-innovation, public service applications, demand stimulation, networking, clusters and open innovation through smart specialisation, and supporting technological and applied research, pilot lines, early product validation actions, advanced manufacturing capabilities and first production, in particular in key enabling technologies and diffusion of general purpose technologies

Partners (1)

Lead Partner: Region Sjælland - Sjællands Universitetshospital

Address: 4600 Køge Køge, Denmark

Legal status: n/a

Partners map

Partners and Projects info

Region Sjælland - Sjællands Universitetshospital

Treatment of COVID-19 late consequences

Lead partner

Project partner

Summary

Project name (EN): Treatment of COVID-19 late consequences

Project name (DA): Behandling af COVID-19 senfølger

Project acronym: Behandling af COVID-19 senfølger

Project start date: 2021-05-01

Project end date: 2022-09-30

Project status: closed

Total budget/expenditure: EUR 4 839 186.00

Total EU funding (amount): EUR 3 629 271.00

Co-financing sources:

ERDF: Amount, EUR 3 629 271.00.

Information regarding the data in keep.eu on the programme financing this project

Financing programme

2014 - 2020 INTERREG V-A Sweden - Denmark - Norway (Öresund - Kattegat - Skagerrak)

Last month that data in keep.eu was retrieved from the Programme's website or received from the Programme

2021-11-01

No. of projects in keep.eu / Total no. of projects (% of projects in keep.eu)

88 / 88 (100%)

No. of project partnerships in keep.eu / Total no. of project partnerships (% of project partnerships in keep.eu)

88 / 325 (27.08%)

Notes on the data

Part of the data was provided by the programme in 2017-02-14, part of the data was retrieved by Interact from the programme´s website on the 2019-09-26, 2020-04-18, 2020-11-09, 2021-03-08 and 2021-11-11. With regard to the collected data from the programme´s website the Specific objectives were derived from Thematic objectives. Regarding partners only data only main partners is available. Achievements were retrieved by Interact from the Programme website (http://www.interreg-oks.eu/), or a website directly linked from it, on 2021-11-30. Fields project name and description (from 88 projects) translated from Danish, Swedishand Norwegian into English using the European Commission's eTranslation machine translation service.

The financial data featured in keep.eu for this programme, it's projects and its partners is not exact and should be taken as a reference only.

Languages

Contact Form

Treatment of COVID-19 late consequences

Description

Thematic information

Partners (1)

Partners map

Summary

Information regarding the data in keep.eu on the programme financing this project

Disclaimer